sitagliptin/metformin apc 50mg/500mg modified-release tablet
apc instytut sp. z.o.o. (0000011610) ul. aleje jerozolimskie 146c, warsaw, mazowieckie, 02-305 - sitagliptin hydrochloride monohydrate; metformin hydrochloride - modified-release tablet - 50mg/500mg - sitagliptin hydrochloride monohydrate (8000004805) 56,69mg; metformin hydrochloride (0001115704) 500mg
sitagliptin/metformin apc 50mg/1000mg modified-release tablet
apc instytut sp. z.o.o. (0000011610) ul. aleje jerozolimskie 146c, warsaw, mazowieckie, 02-305 - sitagliptin hydrochloride monohydrate; metformin hydrochloride - modified-release tablet - 50mg/1000mg - sitagliptin hydrochloride monohydrate (8000004805) 56,69mg; metformin hydrochloride (0001115704) 1000mg
competact
cheplapharm arzneimittel gmbh - pioglitazone, metformin hydrochloride - Σακχαρώδης διαβήτης τύπου 2 - Φάρμακα που χρησιμοποιούνται στον διαβήτη - competact is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.
competact (15+850)mg/tab f.c.tab
takeda global research and development centre (europe)ltd uk - metformin and pioglitazone - ΕΠΙΚΑΛΥΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - (15+850)mg/tab - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
sitagliptin+metformin/grindeks f.c.tab (50+1000) mg/tab
jointstock company "grindeks", latvia (ΛΕΤΟΝΙΑ) krustpils 53,, lv-1057 riga - sitagliptin hydrochloride monohydrate; metformin hydrochloride - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - (50+1000) mg/tab - sitagliptin hydrochloride monohydrate 56,68mg; metformin hydrochloride 1.000mg - combinations of oral blood glucose lowering drugs
sitagliptin+metformin/grindeks f.c.tab (50+850) mg/tab
jointstock company "grindeks", latvia (ΛΕΤΟΝΙΑ) krustpils 53,, lv-1057 riga - sitagliptin hydrochloride monohydrate; metformin hydrochloride - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - (50+850) mg/tab - sitagliptin hydrochloride monohydrate 56,68mg; metformin hydrochloride 850mg - combinations of oral blood glucose lowering drugs
sitagliptin+metformin/apc con.r.tab (50+1000)mg/tab
apc instytut spÓŁka z ograniczonĄ odpowiedzialnoŚ, poland ul. al. aleje jerozolimskie nr 146c, 02-305 warsawa - sitagliptin hydrochloride monohydrate; metformin hydrochloride - con.r.tab (ΔΙΣΚΙΟ ΕΛΕΓΧΟΜΕΝΗΣ ΑΠΟΔΕΣΜΕΥΣΗΣ) - (50+1000)mg/tab - sitagliptin hydrochloride monohydrate 56,69mg; metformin hydrochloride 1.000mg - combinations of oral blood glucose lowering drugs
sitagliptin+metformin/apc con.r.tab (50+500)mg/tab
apc instytut spÓŁka z ograniczonĄ odpowiedzialnoŚ, poland ul. al. aleje jerozolimskie nr 146c, 02-305 warsawa - sitagliptin hydrochloride monohydrate; metformin hydrochloride - con.r.tab (ΔΙΣΚΙΟ ΕΛΕΓΧΟΜΕΝΗΣ ΑΠΟΔΕΣΜΕΥΣΗΣ) - (50+500)mg/tab - sitagliptin hydrochloride monohydrate 56,69mg; metformin hydrochloride 500mg - combinations of oral blood glucose lowering drugs
sitagliptin+metformin/apc con.r.tab (100+1000)mg/tab
apc instytut spÓŁka z ograniczonĄ odpowiedzialnoŚ, poland ul. al. aleje jerozolimskie nr 146c, 02-305 warsawa - sitagliptin hydrochloride monohydrate; metformin hydrochloride - con.r.tab (ΔΙΣΚΙΟ ΕΛΕΓΧΟΜΕΝΗΣ ΑΠΟΔΕΣΜΕΥΣΗΣ) - (100+1000)mg/tab - sitagliptin hydrochloride monohydrate 113,38mg; metformin hydrochloride 1.000mg - combinations of oral blood glucose lowering drugs
sitagliptin+metformin/viofar f.c.tab (50+850)mg/tab
viofar ΕΠΕ Εθν. Αντιστάσεως και Τριφυλλίας, 136 71 136 71, Αχαρναί 2468725, 2468185 - sitagliptin hydrochloride monohydrate; metformin hydrochloride - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - (50+850)mg/tab - sitagliptin hydrochloride monohydrate 54,48mg; metformin hydrochloride 850mg - combinations of oral blood glucose lowering drugs